PMC:7534795 / 106616-106778 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T61540","span":{"begin":92,"end":106},"obj":"Chemical"},{"id":"T46668","span":{"begin":96,"end":106},"obj":"Chemical"},{"id":"T114","span":{"begin":121,"end":126},"obj":"Chemical"}],"attributes":[{"id":"A93780","pred":"chebi_id","subj":"T61540","obj":"http://purl.obolibrary.org/obo/CHEBI_35457"},{"id":"A2116","pred":"chebi_id","subj":"T46668","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A21579","pred":"chebi_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"}],"text":"Therefore, intervention with treatments to correct an imbalance in the RAAS system, such as ACE inhibitors, ARBs and n-3 PUFAs, can possibly improve the outcomes."}

{"project":"LitCovid-sentences","denotations":[{"id":"T662","span":{"begin":0,"end":162},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Therefore, intervention with treatments to correct an imbalance in the RAAS system, such as ACE inhibitors, ARBs and n-3 PUFAs, can possibly improve the outcomes."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2996","span":{"begin":92,"end":95},"obj":"Gene"},{"id":"2999","span":{"begin":117,"end":126},"obj":"Chemical"}],"attributes":[{"id":"A2996","pred":"tao:has_database_id","subj":"2996","obj":"Gene:1636"},{"id":"A2999","pred":"tao:has_database_id","subj":"2999","obj":"MESH:D015525"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Therefore, intervention with treatments to correct an imbalance in the RAAS system, such as ACE inhibitors, ARBs and n-3 PUFAs, can possibly improve the outcomes."}